Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 59, Issue 4, Pages 1459-1470
Publisher
Wiley
Online
2013-11-09
DOI
10.1002/hep.26929
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Slug promoted vasculogenic mimicry in hepatocellular carcinoma
- (2013) Dan Sun et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2
- (2012) Chunmei Piao et al. CELL CYCLE
- Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma
- (2012) Xijun Wang et al. HEPATOLOGY
- Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma
- (2012) Jian Huang et al. NATURE GENETICS
- The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion
- (2012) Nina Fenouille et al. PLoS One
- Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer
- (2011) X. Liu et al. CANCER RESEARCH
- Snail2 is an Essential Mediator of Twist1-Induced Epithelial Mesenchymal Transition and Metastasis
- (2011) E. Casas et al. CANCER RESEARCH
- Metastasis and AKT activation
- (2011) Meng Qiao et al. CELL CYCLE
- Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin β1 signaling in human hepatocellular carcinoma
- (2011) Hong Li et al. HEPATOLOGY
- Loss of phosphatase and tensin homolog enhances cell invasion and migration through aKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance
- (2011) Karen Man-Fong Sze et al. HEPATOLOGY
- p53 and its mutants in tumor cell migration and invasion
- (2011) Patricia A. J. Muller et al. JOURNAL OF CELL BIOLOGY
- p53R2 Inhibits the Proliferation of Human Cancer Cells in Association with Cell-Cycle Arrest
- (2011) K. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro
- (2010) Teppei Morikawa et al. HUMAN PATHOLOGY
- Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2
- (2010) Naihan Xu et al. JOURNAL OF CELL BIOLOGY
- Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines
- (2010) Xin-Bo Xue WORLD JOURNAL OF GASTROENTEROLOGY
- NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53
- (2009) D. F. Calvisi et al. CANCER RESEARCH
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Ribonucleotide reductase small subunit p53R2 suppresses MEK–ERK activity by binding to ERK kinase 2
- (2009) C Piao et al. ONCOGENE
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
- Anti-cancer Effects of JKA97 Are Associated with Its Induction of Cell Apoptosis via a Bax-dependent and p53-independent Pathway
- (2008) Wenjing Luo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation